Joanna Wardlaw

LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke 22:08
LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke
Joanna Wardlaw et al. • 23 Feb 2023
Protecting the endothelium as a therapeutic strategy in cerebral small vessel disease 5:05
Protecting the endothelium as a therapeutic strategy in cerebral small vessel disease
Joanna Wardlaw et al. • 23 Feb 2023
Brain fluid clearance pathways in cerebrovascular disease 4:18
Brain fluid clearance pathways in cerebrovascular disease
Joanna Wardlaw • 27 Apr 2022
The goals and objectives of ESOC 2022 2:21
The goals and objectives of ESOC 2022
Joanna Wardlaw • 27 Apr 2022
An overview of ESOC 2022: major topics and important clinical trials 4:06
An overview of ESOC 2022: major topics and important clinical trials
Joanna Wardlaw • 27 Apr 2022
SVD is a key area of stroke research 2:13
SVD is a key area of stroke research
Joanna Wardlaw • 31 Aug 2021
Key areas for stroke development in 2021 and beyond 4:11
Key areas for stroke development in 2021 and beyond
Joanna Wardlaw • 31 Aug 2021
Advances in acute ischemic stroke at ESOC 2021 1:37
Advances in acute ischemic stroke at ESOC 2021
Joanna Wardlaw • 31 Aug 2021
What are you looking forward to at ESOC 2021? 1:31
What are you looking forward to at ESOC 2021?
Joanna Wardlaw • 31 Aug 2021
What’s to come at ESOC 2021? 2:06
What’s to come at ESOC 2021?
Joanna Wardlaw • 31 Aug 2021
Hemorrhagic stroke news at ESOC 2021 2:18
Hemorrhagic stroke news at ESOC 2021
Joanna Wardlaw • 31 Aug 2021
The content of VJNeurology is intended for healthcare professionals